Amoxicillin

Producers shown on SFDA

(Record date:25/08/2021）

Producers shown on EP

(Quoted from EP website；record date:25/08/2021）

Producer:Inner Mongolia Changsheng Pharmaceutical Co., Ltd a wholly foreign-owned enterprise, was established in October 2003. It mainly produces and operates amoxicillin, ampicillin API and related pharmaceutical intermediates. There are more than 1300 employees, the company covers an area of 1500 mu, the cumulative investment in fixed assets has reached 2.5 billion yuan, and the cumulative tax paid has exceeded 1 billion yuan; In 2019, the sales revenue was nearly 1.5 billion yuan and the profit and tax was 150 million yuan; The main products have passed the international high-end certification such as FDA of the United States and CEP of the European Union; Export products account for 40% of the company's total sales, and the products are sold to more than 20 countries and regions around the world.

Staff size:900-999 persons

Registered capital:Hong Kong dollar 271.6472 million

Producer:Zhuhai United Laboratories Co., Ltd. is a subsidiary of The United Laboratories International Holdings Limited (United Lab). United Lab now has 11 major series of preparation products, more than 60 varieties, more than 120 product specifications, and nearly 50 varieties of 5 major series of API and intermediate products. All workshops of UL have passed the new version of GMP certification in China, and many products have successively obtained EU GMP certification and US FDA certification. With advanced enzymatic production technology, UL has become the first enterprise in China to obtain the EU CEP certificate of enzymatic amoxicillin, and a number of scientific and technological achievements have obtained national patents.

United Labowns advanced production equipment and adequate production capacity. Every year, it can produce 1.8 billion capsules, 1 billion tablets, 134 million sachets of granules, 86 million sachets of suspension, 20 million vials of oral solution, 117 million vials of powder injections, 37.8 million tubes of ointments, 28 million vials of lyophilized powder for injection, 24 million tubes of eye drops and about 300 million tubes of insulin preparation.

Staff size:2000-2999 persons

Registered capital:RMB 1 billion 678 million 396 thousand

Producer:The United Laboratories (inner Mongolia) Co., Limited is subordinate to UL International Holding Co., Ltd. and is the fifth pharmaceutical factory built in China. At present, the total investment is nearly 8.1 billion yuan and the total number of employees is more than 5400. It is the production base with the largest investment and the most complete industrial chain of UL and one of the largest drug production bases in Northwest China.

Staff size:5000-5999 persons

Registered capital:RMB 2920 million

Producer:Huabei Pharmaceutical Group Co., Ltd. is the largest pharmaceutical enterprise in China, located in Shijiazhuang, the capital of Hebei Province.

By the end of 2018, Huayao group had total assets of 20.6 billion yuan, nearly 15000 employees, more than 40 subsidiaries (branches), and three national innovation platforms: National Engineering Research Center for microbial drugs, State Key Laboratory for antibody drug development, national local joint engineering laboratory for antibiotic enzyme catalysis and crystallization technology. Its main products are chemical pharmaceuticals There are nearly 1000 product specifications in the fields of modern biotechnology drugs, vitamins and nutritional health products, modern traditional Chinese medicine, biological agricultural and veterinary drugs, and the treatment fields cover anti infection, cardio cerebrovascular, nephropathy, anti-tumor and immune regulation. The process route and production layout of the main production units are designed and implemented in accordance with the current version of GMP in Europe and America and the new version of GMP in China, It has a modern pharmaceutical production platform with international leading level.

Staff size:900-999 persons

Registered capital:RMB 128.68952 million 

Producer:Sinopharm Weiqida Pharmaceutical Co.,Led.is a wholly-owned subsidiary of Shanghai Modern Pharmaceutical Co., Ltd. the company is located in the pharmaceutical industrial park of Datong Economic and Technological Development Zone, Shanxi Province. Its holding Sinopharm group Datong Weiqida Zhongkang Pharmaceutical Co., Ltd. covers a total area of 1314 Mu and has 4310 employees.

Wichita and Wichita Zhongkang have the production capacity of three mother nuclei of 7aca, 6apa and 7adca antibiotics, and form a complete industrial chain of cephalosporins and penicillins from basic raw materials to terminal preparations. Their products are highly competitive in domestic and foreign markets. All production workshops of the company have passed the new national GMP certification, and the production workshops of core products are designed and constructed in accordance with the standards of FDA and CEP of the European Union. The company has set up product R & D centers and joint laboratories in Shanghai, Guangzhou and the headquarters, formed a trinity scientific and technological R & D system, and has a scientific and technological R & D team with high quality and strong professional ability.

Staff size:About 4300 persons

Registered capital:RMB 112 million

Staff size:/

Registered capital:RMB 52.43152 million

Producer:Henan Lvyuan Pharmaceutical Co., Ltd. is a modern high-tech pharmaceutical joint-stock enterprise jointly invested and constructed by Liuzhuang village and several domestic companies. It covers an area of 266800 square meters, a planned construction area of 110000 square meters and a total investment of more than 1 billion yuan

Lvyuan pharmaceutical attaches great importance to the introduction, training and development of talents, and has established a perfect quality assurance system. The company has more than 1000 employees, of which more than 30% are professional technicians, who are fully responsible for the R & D and quality supervision of the company's products.

Staff size:100-199 persons

Registered capital:RMB 650 million

Producer:CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.is a joint venture invested and established by CSPC Pharmaceutical Group Co., Ltd. in the mainland. It is a professional production base of antibiotic raw materials and preparations in China and a major supplier of non patented drugs in China. The market share of amoxicillin dispersible tablets and Amoxicillin Capsules produced by the company ranks first in the industry.

The "zero defect items" of cephalosporin powder injection, tablet and capsule passed the FDA certification for the first time; The annual output is 1.2 billion powder injections, 4.4 billion capsules and 800 million tablets; It is divided into four dosage forms: powder injection, capsule, tablet and granule; More than 150 specifications of antibiotics were produced. All kinds of products have passed GMP certification and meet the latest national standards.

Staff size:2000-2999 persons
Registered capital:RMB 678 million 555 thousand and 900

At present, Sichuan ren'an Pharmaceutical Co., Ltd. has two production bases, which are located in Yuechi County, Guang'an City, Sichuan Province and Qingbaijiang District, Chengdu City. Its headquarters is set up in Yuechi production base. Yuechi production base covers an area of 325 mu, with a construction area of 55636.83 square meters. It has 9 GMP production workshops, 1 pilot workshop and more than 700 employees. It mainly produces penicillin sterile API, cephalosporin non sterile API, ordinary non sterile API (including ephedrine), precursor API, etc., and has 55 API production approvals, Among them, 18 varieties have passed the national GMP certification and achieved industrial production, and the sterile API "ampicillin sodium" has passed the two international GMP certification of EU and Japan. Qingbaijiang production base covers an area of 30 mu and a construction area of 6100 square meters. It has two GMP production workshops, mainly producing ordinary non sterile API.

Staff size:700-799 persons

Registered capital:RMB 180 million

Producer:Shandong Bairui Pharmaceutical Co., Ltd. is a semi synthetic antibiotic API production base integrating scientific research, development, pilot test, production and sales. The company has been cancelled.

Staff size:/

Registered capital:RMB 12 million

Producer:Reyoung Pharmaceutical Co., Ltd, which was converted into a limited company under the PRC law in 1998 and is now a Singapore-listed company, was established in 1966. The company is an ISO9001、ISO14001、OHS18001 authentication enterprise and possess postdoctoral programme and ERP system and so on. The trademark of “reyoung” is famous trademark of China.

Staff size:3000-3999 persons

Registered capital:RMB 12 million

Producer:Livzon Syntpharm Co.,ltd.(zhuhaiftz) a wholly-owned subsidiary of Lizhu Pharmaceutical Group Co., Ltd., was established in 1993 and is located in Zhuhai Free Trade Zone, Guangdong Province.

By the end of 2008, the company had invested more than 300 million in fixed assets, covering an area of about 100000 square meters. It is a API base based on cephalosporin semi synthetic antibiotics built according to GMP standards. The production lines of the whole company have passed GMP certification. The production process and economic and technical indexes of all products have reached the domestic advanced level, and the product quality meets the CP and USP Pharmacopoeia standards. With an annual output value and sales of more than 600 million yuan, it has become one of the largest cephalosporin sterile API production bases in China.

Staff size:400-499 persons

Registered capital:RMB 128.28 million

Producer:Harbin Pharmaceutical Group Co., Ltd. General Pharm. Factory is a key antibiotic production base in China and a large national first-class pharmaceutical enterprise. It is the backbone of Harbin Pharmaceutical Group and one of the pillar enterprises of Harbin local economic development. Harbin Pharmaceutical adheres to the enterprise philosophy of "above quality and pursuing human health", carries forward the enterprise spirit of "carrying things with great virtue and being cautious and strong", follows the business purpose of "the best quality and the best service", constantly develops and innovates and strives to forge ahead.

The Pharmaceutical General Factory of Harbin Pharmaceutical Group is subordinate to Harbin Pharmaceutical Group Co., Ltd. It is a Sino foreign joint-stock enterprise. It is a key antibiotic production base in China, a national large-scale first-class pharmaceutical enterprise, and one of China's 500 large industrial enterprises.

Staff size:3000-3999 persons

Registered capital:---

Staff size:About 1700 persons

Registered capital:RMB 2 billion 63 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978